Childhood cancers trials in China

In China 609 Also abroad 2483

609 trials · From ClinicalTrials.gov, checked 15 November 2026. Ask the study team whether a trial fits you.

Phase 1/2Taking people
A Multicenter, Open-Label, Non-Randomized, Single-Arm Clinical Study of Nanobody CD5-CAR T Cell Therapy for Refractory/Relapsed T Lymphocyte Malignancies
Where
Beijing, Chengdu, Shanghai
Age
1 year to 70 years
People
54
Run by
Beijing GoBroad Hospital
See details and how to joinNCT07070323
No phaseTaking people
MR Microstructural Imaging for Prostate Cancer Diagnosis
Where
Beijing, Dalian, Hangzhou, Nanjing, Zhengzhou
People
2,000
Run by
First Affiliated Hospital of Zhejiang University
See details and how to joinNCT07249281
Phase 2Taking people
Assessment of Senl_B19 CAR-T Cells in Relapsed/Refractory CD19+ B-ALL
Where
Beijing
Age
3 years to 25 years
People
59
Run by
Hebei Senlang Biotechnology Inc., Ltd.
See details and how to joinNCT07244406
Phase 2Taking people
Inotuzumab Ozogamicin in the Treatment of MRD+ After HSCT of ALL
Where
Suzhou
Age
15 years to 65 years
People
42
Run by
Sheng-Li Xue, MD
See details and how to joinNCT05940961
Phase 1Taking people
Blinatumomab and Auto-HSCT Sandwich Strategy as Consolidation Therapy for B-ALL
Where
Suzhou
Age
15 years to 65 years
People
4
Run by
The First Affiliated Hospital of Soochow University
See details and how to joinNCT06507514
No phaseTaking people
Zanubrutinib Combined With Rituximab in the Treatment for Patients With Marginal Zone Lymphoma
Where
Zhengzhou
People
30
Run by
Henan Cancer Hospital
See details and how to joinNCT07233720
Phase 2Taking people
Phase II, Open-label, Multicenter Study to Evaluate the Efficacy and Safety of HLX43 (an Anti-PD-L1 ADC) in Subjects With Advanced Colorectal Cancer
Where
Beijing, Jinan
Age
18 days to 75 days
People
60
Run by
Shanghai Henlius Biotech
See details and how to joinNCT07106892
No phaseTaking people
ID Of Prognostic Factors In Mycosis Fungoides/Sezary Syndrome
Where
Beijing
People
2,000 worldwide
Run by
Stanford University
See details and how to joinNCT02848274
Phase 4Taking people
Ondansetron Orodispersible Film for Vomiting Prevention in Pediatric Radiotherapy
Where
Chongqing
Age
1 year to 14 years
People
60
Run by
Chongqing University Cancer Hospital
See details and how to joinNCT07217600
No phaseTaking people
High-Altitude Hematology Observation-Stem Cell Transplantation (HALO-SCT)
Where
Xining
People
1,000
Run by
Yigeng Cao,MD,PhD
See details and how to joinNCT07205523
Phase 2Taking people
Vebreltinib for Advanced or Metastatic CCS
Where
Hangzhou
Age
12 years and over
People
30
Run by
Second Affiliated Hospital, Zhejiang University, School of Medicine
See details and how to joinNCT07153887
No phaseNot yet taking people in China
A Real-World Study of IBI351 for KRAS G12C+ NSCLC in China
Where
Guangzhou
People
600
Run by
Guangdong Association of Clinical Trials
See details and how to joinNCT07198620
Phase 2Taking people
Orelabrutinib and Rituximab With Optional Autologous Hematopoietic Stem Cell Transplantation in MCL Treatment
Where
Shanghai
Age
14 years and over
People
45
Run by
Ruijin Hospital
See details and how to joinNCT07199296
No phaseTaking people
Clinical Application of Somatostatin Receptor and Norepinephrine Transporter Targeted Imaging for Diagnosis and Staging of Neuroblastoma and Pheochromocytoma/Paraganglioma
Where
Nanjing
Age
6 months and over
People
30
Run by
Nanjing First Hospital, Nanjing Medical University
See details and how to joinNCT07195500
No phaseTaking people
A Clinical Study on the Efficacy and Safety of Methotrexate (MTX) or Thiotepa (for MTX Intolerance) or Temozolomide (TMZ) Combined With Orelabrutinib and Selinexor in Relapsed/Refractory Primary or Secondary Central Nervous System Lymphoma（SELINA）
Where
Shanghai
Age
14 years to 80 years
People
25
Run by
Ruijin Hospital
See details and how to joinNCT07191431
No phaseTaking people
Pucotenlimab Combined With Lenvatinib and Chemotherapy in the Treatment of Advanced, Relapsed/Refractory Hepatoblastoma in Children
Where
Guangdong
Age
2 years to 18 years
People
24
Run by
Sun Yat-sen University
See details and how to joinNCT07188311
Phase 2Taking people
Treatment of Newly Diagnosed Central Malignant Germ Cell Tumor People With Teniposide Injection Combined With Cisplatin.
Where
Guangzhou
Age
5 years and over
People
40
Run by
Chengcheng Guo
See details and how to joinNCT07188441
No phaseTaking people
Multicentric Database for Solid Pseudopapillary Neoplasm of the Pancreas
Where
Shanghai
People
2,000
Run by
Fudan University
See details and how to joinNCT07183280
No phaseTaking people
Disitamab Vedotin (RC48-ADC) in Breast Cancer
Where
Shanghai
People
45
Run by
RenJi Hospital
See details and how to joinNCT05851677
No phaseTaking people
ImmunoPET Targeting Trophoblast Cell-surface Antigen 2 (Trop-2) in Craniopharyngioma Patients
Where
Beijing
Age
14 years to 80 years
People
20
Run by
Deling Li
See details and how to joinNCT07177482
Phase 1Taking people
BCMA-CD19 cCAR in Multiple Myeloma and Plasmacytoid Lymphoma
Where
Chengdu, Shenzhen
People
12
Run by
iCell Gene Therapeutics
See details and how to joinNCT04162353
No phaseNot yet taking people in China
Risk-adapted Therapeutic Strategy in +1q NDMM
Where
Changchun
People
200
Run by
FengYan Jin
See details and how to joinNCT07045168
Phase 1/2Taking people
Study of ICP-723 in Patients With Advanced Solid Tumors or Primary Central Nervous System Tumors
Where
Guangzhou
Age
2 years and over
People
70
Run by
Beijing InnoCare Pharma Tech Co., Ltd.
See details and how to joinNCT05745623
Phase 3Taking people
Newly-diagnosed Pediatric Ph-positive B-ALL Protocol
Where
Changsha, Chengdu, Chongqing, Fuzhou, Guangzhou, Guiyang, Hefei, Jinan, Nanchang, Nanjin, Qingdao, Shanghai, Shenzhen, Suzhou, Tianjin, Wuhan
Age
1 month to 18 years
People
150 worldwide
Run by
Institute of Hematology & Blood Diseases Hospital, China
See details and how to joinNCT07152041
Phase 1/2Taking people
A Phase I/II Clinical Trial of ICP-723 in the Treatment of Advanced Solid Tumors
Where
Beijing, Changsha, Guangdong, Guangzhou, Hangzhou, Harbin, Hefei, Jinan, Kunming, Luoyang, Nanchang, Nanjing, Qingdao, Shijiazhuang, Taiyuan, Wuhan, Wuxi, Zhengzhou, Zhuhai
Age
12 years and over
People
310
Run by
Beijing InnoCare Pharma Tech Co., Ltd.
See details and how to joinNCT04685226